Lineage Cell Therapeutics Inc (LCTX): Kapitalflussrechnung
Kennzahl in 1000 USD | TTM 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 | 2001-12-31 | 2000-12-31 | 1999-12-31 | 1998-12-31 | 1997-12-31 | 1996-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 13.083 | 14.556 | 9.499 | 8.945 | 14.703 | 3.896 | 773 | 1.478 | 1.416 | 1.792 | 2.252 | 2.534 | 1.946,372 | 2.861,007 | 1.692,869 | 4.354,762 | 3.680,3 | 1.925,168 | 1.503,792 | 1.046,121 | 1.162,015 | 903,2 | 688,377 | 556,422 | 387,02 | 151,917 | 52,492 | 1.037,5 | 300 | 100 | 100 |
Cashflow aus operativer Geschäftstätigkeit | -23.815,999 | -18.919 | -23.092 | -28.566 | 1.059 | -23.561 | -19.753 | -31.947 | -30.882 | -30.517 | -42.326 | -44.544 | -38.854,2 | -29.508,613 | -19.679,518 | -13.593,916 | -7.732,884 | -4.259,938 | -1.604,245 | -1.239,98 | -1.262,219 | -1.414,148 | -1.536,696 | -654,144 | -2.129,155 | -3.209,834 | -4.857,03 | -4.394,901 | -2.100 | -1.300 | -2.100 |
▸ Operative Cashflow Marge | -182,04% | -129,97% | -243,1% | -319,35% | 7,2% | -604,75% | -2.555,37% | -2.161,5% | -2.180,93% | -1.702,96% | -1.879,48% | -1.757,85% | -1.996,24% | -1.031,41% | -1.162,5% | -312,16% | -210,12% | -221,28% | -106,68% | -118,53% | -108,62% | -156,57% | -223,23% | -117,56% | -550,14% | -2.112,89% | -9.252,9% | -423,6% | -700% | -1.300% | -2.100% |
Investitionsausgaben (CapEx) | 233 | 522 | 565 | 674 | 413 | 354 | 64 | 440 | 3.287 | 1.326 | 2.526 | 5.334 | 483,097 | 2.277,168 | 400,81 | 961,781 | 435,771 | 61,276 | 859,872 | 6,473 | 10,664 | - | - | - | 3,831 | 5,116 | 33,402 | 161,719 | 100 | 100 | - |
Cashflow aus Investitionstätigkeit | -13.712 | -13.457 | -2.308 | 46.449 | -46.159 | 9.745 | 13.038 | 16.957 | 11.816 | -10.225 | -10.889 | -7.441 | -1.007,804 | -3.665,587 | -104,687 | -1.202,713 | 3.197,419 | -46,226 | -909,872 | -6,473 | -10,664 | - | - | - | -3,831 | -5,116 | -33,402 | -161,719 | -100 | - | - |
Cashflow aus Finanzierungstätigkeit | 32.240 | 26.950 | 35.857 | 6.423 | 1.632 | 36.930 | 29.865 | 617 | 5.774 | 55.391 | 32.782 | 64.775 | 63.623,243 | 34.263,608 | 1.913,378 | 3.862,414 | 25.767,456 | 16.482,966 | 2.516,895 | 694,937 | 0,126 | 1.877,16 | 2.190,274 | 86,896 | 1.764,67 | 3.549,36 | 915,964 | 7.420,412 | 400 | 6.700 | 1.100 |
Freier Cashflow | -24.048,999 | -19.441 | -23.657 | -29.240 | 646 | -23.915 | -19.817 | -32.387 | -34.169 | -31.843 | -44.852 | -49.878 | -39.337,297 | -31.785,781 | -20.080,328 | -14.555,697 | -8.168,655 | -4.321,214 | -2.464,117 | -1.246,453 | -1.272,883 | -1.414,148 | -1.536,696 | -654,144 | -2.132,986 | -3.214,95 | -4.890,432 | -4.556,62 | -2.200 | -1.400 | -2.100 |
▸ Freie Cashflow Marge | -183,82% | -133,56% | -249,05% | -326,89% | 4,39% | -613,83% | -2.563,65% | -2.191,27% | -2.413,06% | -1.776,95% | -1.991,65% | -1.968,35% | -2.021,06% | -1.111% | -1.186,17% | -334,25% | -221,96% | -224,46% | -163,86% | -119,15% | -109,54% | -156,57% | -223,23% | -117,56% | -551,13% | -2.116,25% | -9.316,53% | -439,19% | -733,33% | -1.400% | -2.100% |
Ausgeschüttete Dividenden | - | - | - | -37 | - | -7.240 | -25.147 | -40 | -34.409 | -454 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | -41 | -16 | -23 | -37 | -17 | -54 | -27 | -110 | -241 | -888 | 32.997 | 49.750 | 63.494,18 | 35.081,809 | - | - | - | - | - | - | - | -379,984 | -162,453 | - | - | - | -36,177 | -128,024 | -200 | -200 | -200 |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.